Section 102 - Definitions.

UT Code § 26-61-102 (2019) (N/A)
Copy with citation
Copy as parenthetical citation

(1) "Approved study" means a medical research study: (a) the purpose of which is to investigate the medical benefits and risks of cannabinoid products; and (b) that is approved by an IRB.

(a) the purpose of which is to investigate the medical benefits and risks of cannabinoid products; and

(b) that is approved by an IRB.

(2) "Board" means the Cannabinoid Product Board created in Section 26-61-201.

(3) "Cannabinoid product" means the same as that term is defined in Section 58-37-3.6.

(4) "Cannabis" means the same as that term is defined in Section 58-37-3.6.

(5) "Expanded cannabinoid product" means the same as that term is defined in Section 58-37-3.6.

(6) "Institutional review board" or "IRB" means an institutional review board that is registered for human subject research by the United States Department of Health and Human Services.